ArticleClinical and vaccine immunology : CVI2017

GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.

Thomas H King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.